Discover how in vivo genome editing is revolutionizing our understanding of lung cancer genetics through functional genomics and CRISPR technology.
Explore how CRISPR-engineered PD-1 deficient T cells are transforming treatment for advanced non-small cell lung cancer through groundbreaking gene editing technology.
Discover how CAMKK1 polymorphism rs7214723 influences lung cancer prognosis through groundbreaking genetic research and CRISPR validation.